MedTrace Logo

Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease

NCT00677638 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-12-03

No results posted yet for this study

Summary

A prospective single arm study evaluating feasibility and safety of a catheter-based transapical implantation of the Ventor Embracer™ aortic valve bioprosthesis in patients with severe aortic valve disease, specifically aortic stenosis, who are at elevated risk for standard surgical valve replacement.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

Ventor Embracer

Implantation of Ventor Embracer

Sponsors & Collaborators

  • Ventor Technologies

    lead INDUSTRY

Principal Investigators

  • Jochen Schaefers, MD · Universitatsklinikum des Saarlandes

  • Friedrich Mohr, MD · Universität Leipzig

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-01-31
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00677638 on ClinicalTrials.gov